Further highlighting the importance of ROS, NFE2-Like BZIP Transcription Factor 2 (NFE2L2), which is a key regulator of cellular antioxidant response, is inhibited in MM with t(4;14), increasing ROS and MM cell proliferation [13]. Here, NFE2L2 is linked to Miyoshi myopathy.